Hungary

Hungary

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.68 (0.63 - 0.74) 2019 Modelled IHME
0.69 (0.64 - 0.74) 2018 Modelled IHME
0.69 (0.64 - 0.75) 2017 Modelled IHME
0.69 (0.64 - 0.75) 2016 Modelled IHME
0.69 (0.64 - 0.75) 2015 Modelled IHME
0.69 (0.64 - 0.75) 2014 Modelled IHME
0.69 (0.64 - 0.75) 2013 Modelled IHME
0.7 (0.64 - 0.76) 2012 Modelled IHME
0.7 (0.64 - 0.76) 2011 Modelled IHME
0.7 (0.65 - 0.77) 2010 Modelled IHME
0.7 (0.65 - 0.77) 2009 Modelled IHME
0.7 (0.65 - 0.77) 2008 Modelled IHME
0.71 (0.65 - 0.77) 2007 Modelled IHME
0.71 (0.65 - 0.77) 2006 Modelled IHME
0.71 (0.65 - 0.77) 2005 Modelled IHME
0.71 (0.65 - 0.77) 2004 Modelled IHME
0.71 (0.65 - 0.78) 2003 Modelled IHME
0.72 (0.65 - 0.78) 2002 Modelled IHME
0.72 (0.65 - 0.79) 2001 Modelled IHME
0.72 (0.65 - 0.79) 2000 Modelled IHME
0.73 (0.65 - 0.79) 1999 Modelled IHME
0.73 (0.66 - 0.79) 1998 Modelled IHME
0.73 (0.67 - 0.79) 1997 Modelled IHME
0.74 (0.67 - 0.79) 1996 Modelled IHME
0.74 (0.67 - 0.80) 1995 Modelled IHME
0.74 (0.67 - 0.80) 1994 Modelled IHME
0.74 (0.68 - 0.80) 1993 Modelled IHME
0.74 (0.67 - 0.81) 1992 Modelled IHME
0.74 (0.67 - 0.81) 1991 Modelled IHME
0.74 (0.66 - 0.82) 1990 Modelled IHME
0.4 (0.10 - 1) 2009 Survey/reported Treso B, 2012
0.45 (0.19 - 0.96) 2015 Modelled WHO
0.4 (0.40 - 0.50) 2016 Modelled Razavi-Shearer et al, 2018
0.4 (0.10 - 1) 2009 Survey/reported ECDC
0.53 (0.46 - 0.61) 2013 Modelled Schweitzer et al, 2015
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.22 (0.16 - 0.30) 2019 Modelled IHME
0.22 (0.17 - 0.29) 2018 Modelled IHME
0.22 (0.17 - 0.29) 2017 Modelled IHME
0.22 (0.16 - 0.29) 2016 Modelled IHME
0.22 (0.16 - 0.30) 2015 Modelled IHME
0.22 (0.16 - 0.30) 2014 Modelled IHME
0.22 (0.16 - 0.30) 2013 Modelled IHME
0.23 (0.16 - 0.30) 2012 Modelled IHME
0.23 (0.16 - 0.30) 2011 Modelled IHME
0.23 (0.17 - 0.31) 2010 Modelled IHME
0.23 (0.17 - 0.30) 2009 Modelled IHME
0.23 (0.17 - 0.30) 2008 Modelled IHME
0.23 (0.17 - 0.30) 2007 Modelled IHME
0.23 (0.17 - 0.31) 2006 Modelled IHME
0.23 (0.17 - 0.31) 2005 Modelled IHME
0.23 (0.17 - 0.31) 2004 Modelled IHME
0.24 (0.17 - 0.31) 2003 Modelled IHME
0.24 (0.18 - 0.31) 2002 Modelled IHME
0.24 (0.18 - 0.31) 2001 Modelled IHME
0.24 (0.18 - 0.32) 2000 Modelled IHME
0.25 (0.19 - 0.32) 1999 Modelled IHME
0.25 (0.19 - 0.33) 1998 Modelled IHME
0.26 (0.19 - 0.33) 1997 Modelled IHME
0.27 (0.20 - 0.34) 1996 Modelled IHME
0.27 (0.20 - 0.35) 1995 Modelled IHME
0.27 (0.20 - 0.35) 1994 Modelled IHME
0.27 (0.20 - 0.35) 1993 Modelled IHME
0.27 (0.20 - 0.35) 1992 Modelled IHME
0.27 (0.20 - 0.35) 1991 Modelled IHME
0.27 (0.19 - 0.35) 1990 Modelled IHME
0.44 (0.18 - 0.97) 2015 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
2.2 2015 Survey/reported ECDC
0.45 2011 Survey/reported EMCDDA
0.74 2009 Survey/reported EMCDDA
0.51 2008 Survey/reported EMCDDA
0.35 2007 Survey/reported EMCDDA
1.33 2006 Survey/reported EMCDDA
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
2.2 2015 Survey/reported EMCDDA
Prisoners
Download
Value (%) Year Type Source
1.5 (1.20 - 1.80) 2009 Survey/reported Treso B et al, 2012
1.5 2012 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
77,266 (68,566 - 85,062) 1990 Modelled IHME
77,093 (69,493 - 84,251) 1991 Modelled IHME
76,872 (69,773 - 83,757) 1992 Modelled IHME
76,599 (69,844 - 83,216) 1993 Modelled IHME
76,316 (69,664 - 82,604) 1994 Modelled IHME
76,027 (69,446 - 82,395) 1995 Modelled IHME
75,677 (69,235 - 81,705) 1996 Modelled IHME
75,235 (68,759 - 81,559) 1997 Modelled IHME
74,719 (67,924 - 81,096) 1998 Modelled IHME
74,178 (66,887 - 80,812) 1999 Modelled IHME
73,691 (66,147 - 80,914) 2000 Modelled IHME
73,231 (66,331 - 80,096) 2001 Modelled IHME
72,729 (66,141 - 79,541) 2002 Modelled IHME
72,213 (65,945 - 78,931) 2003 Modelled IHME
71,743 (65,842 - 78,263) 2004 Modelled IHME
71,370 (65,443 - 77,683) 2005 Modelled IHME
71,079 (65,457 - 77,360) 2006 Modelled IHME
70,811 (65,380 - 77,077) 2007 Modelled IHME
70,553 (65,131 - 76,736) 2008 Modelled IHME
70,276 (64,865 - 76,522) 2009 Modelled IHME
69,945 (64,505 - 76,339) 2010 Modelled IHME
69,518 (64,021 - 75,570) 2011 Modelled IHME
69,006 (63,683 - 74,807) 2012 Modelled IHME
68,492 (63,271 - 74,383) 2013 Modelled IHME
68,054 (62,743 - 74,214) 2014 Modelled IHME
67,748 (62,496 - 74,076) 2015 Modelled IHME
67,621 (62,772 - 73,285) 2016 Modelled IHME
67,473 (62,445 - 73,229) 2017 Modelled IHME
66,908 (62,040 - 72,223) 2018 Modelled IHME
65,954 (61,121 - 71,681) 2019 Modelled IHME
40,000 (36,000 - 44,000) 2016 Modelled Razavi-Shearer et al, 2018
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.5 (8.58 - 15.30) 2019 Modelled IHME
11.6 (8.74 - 15) 2018 Modelled IHME
11.3 (8.68 - 14.30) 2017 Modelled IHME
11.3 (8.65 - 14.20) 2016 Modelled IHME
11.7 (8.96 - 14.70) 2015 Modelled IHME
11.7 (9 - 14.70) 2014 Modelled IHME
11.9 (9.21 - 15) 2013 Modelled IHME
12.9 (9.93 - 16.20) 2012 Modelled IHME
13.7 (10.60 - 17.10) 2011 Modelled IHME
14.7 (11.40 - 18.30) 2010 Modelled IHME
15.8 (12.20 - 19.50) 2009 Modelled IHME
16.3 (12.70 - 20.10) 2008 Modelled IHME
17.3 (13.50 - 21.30) 2007 Modelled IHME
17.5 (13.60 - 21.50) 2006 Modelled IHME
18 (14 - 22.20) 2005 Modelled IHME
18.2 (14.20 - 22.30) 2004 Modelled IHME
18.8 (14.60 - 23.10) 2003 Modelled IHME
18.9 (14.70 - 23.20) 2002 Modelled IHME
19.2 (15 - 23.70) 2001 Modelled IHME
20.3 (15.70 - 25) 2000 Modelled IHME
21.9 (17 - 27.10) 1999 Modelled IHME
22.3 (17.40 - 27.50) 1998 Modelled IHME
22.1 (17.30 - 27.30) 1997 Modelled IHME
22.8 (17.80 - 28) 1996 Modelled IHME
25 (19.50 - 30.80) 1995 Modelled IHME
25.4 (19.90 - 31.10) 1994 Modelled IHME
25 (19.60 - 30.50) 1993 Modelled IHME
23.3 (18.30 - 28.50) 1992 Modelled IHME
20.5 (16.20 - 25) 1991 Modelled IHME
19.3 (15.30 - 23.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
1,115 (830 - 1,477) 2019 Modelled IHME
1,129 (849 - 1,454) 2018 Modelled IHME
1,105 (846 - 1,393) 2017 Modelled IHME
1,105 (847 - 1,392) 2016 Modelled IHME
1,148 (880 - 1,444) 2015 Modelled IHME
1,155 (886 - 1,445) 2014 Modelled IHME
1,180 (909 - 1,485) 2013 Modelled IHME
1,277 (983 - 1,602) 2012 Modelled IHME
1,362 (1,054 - 1,697) 2011 Modelled IHME
1,465 (1,134 - 1,820) 2010 Modelled IHME
1,575 (1,223 - 1,947) 2009 Modelled IHME
1,630 (1,268 - 2,014) 2008 Modelled IHME
1,738 (1,353 - 2,143) 2007 Modelled IHME
1,757 (1,370 - 2,165) 2006 Modelled IHME
1,821 (1,415 - 2,241) 2005 Modelled IHME
1,837 (1,432 - 2,253) 2004 Modelled IHME
1,901 (1,482 - 2,341) 2003 Modelled IHME
1,921 (1,497 - 2,360) 2002 Modelled IHME
1,959 (1,525 - 2,408) 2001 Modelled IHME
2,070 (1,597 - 2,552) 2000 Modelled IHME
2,244 (1,743 - 2,768) 1999 Modelled IHME
2,289 (1,785 - 2,822) 1998 Modelled IHME
2,270 (1,775 - 2,804) 1997 Modelled IHME
2,342 (1,829 - 2,882) 1996 Modelled IHME
2,580 (2,014 - 3,177) 1995 Modelled IHME
2,620 (2,058 - 3,210) 1994 Modelled IHME
2,582 (2,028 - 3,153) 1993 Modelled IHME
2,410 (1,893 - 2,949) 1992 Modelled IHME
2,128 (1,679 - 2,596) 1991 Modelled IHME
2,006 (1,590 - 2,445) 1990 Modelled IHME
767 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
20 (14 - 28) 2019 Modelled IHME
20 (15 - 28) 2018 Modelled IHME
21 (15 - 29) 2017 Modelled IHME
21 (15 - 29) 2016 Modelled IHME
21 (15 - 29) 2015 Modelled IHME
21 (15 - 29) 2014 Modelled IHME
21 (15 - 29) 2013 Modelled IHME
21 (15 - 29) 2012 Modelled IHME
21 (15 - 29) 2011 Modelled IHME
22 (15 - 29) 2010 Modelled IHME
22 (16 - 29) 2009 Modelled IHME
22 (16 - 29) 2008 Modelled IHME
22 (16 - 30) 2007 Modelled IHME
22 (16 - 30) 2006 Modelled IHME
22 (16 - 30) 2005 Modelled IHME
22 (16 - 30) 2004 Modelled IHME
22 (16 - 30) 2003 Modelled IHME
22 (16 - 30) 2002 Modelled IHME
22 (16 - 29) 2001 Modelled IHME
22 (16 - 29) 2000 Modelled IHME
22 (16 - 29) 1999 Modelled IHME
22 (16 - 30) 1998 Modelled IHME
22 (16 - 30) 1997 Modelled IHME
22 (15 - 30) 1996 Modelled IHME
22 (15 - 30) 1995 Modelled IHME
22 (15 - 30) 1994 Modelled IHME
22 (15 - 30) 1993 Modelled IHME
21 (15 - 30) 1992 Modelled IHME
21 (15 - 29) 1991 Modelled IHME
21 (15 - 29) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
21 2017 Survey/reported EMCDDA, 2019
48 (32 - 91) 2016 Survey/reported Hungary National Institute for Health Development, 2016
21 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.21 (0.98 - 1.49) 2019 Modelled IHME
1.2 (0.98 - 1.47) 2018 Modelled IHME
1.2 (0.97 - 1.47) 2017 Modelled IHME
1.21 (0.99 - 1.47) 2016 Modelled IHME
1.22 (1 - 1.49) 2015 Modelled IHME
1.23 (1.01 - 1.50) 2014 Modelled IHME
1.25 (1.03 - 1.52) 2013 Modelled IHME
1.27 (1.04 - 1.54) 2012 Modelled IHME
1.28 (1.05 - 1.56) 2011 Modelled IHME
1.3 (1.06 - 1.58) 2010 Modelled IHME
1.31 (1.07 - 1.61) 2009 Modelled IHME
1.33 (1.08 - 1.62) 2008 Modelled IHME
1.34 (1.09 - 1.64) 2007 Modelled IHME
1.36 (1.10 - 1.66) 2006 Modelled IHME
1.38 (1.11 - 1.68) 2005 Modelled IHME
1.4 (1.13 - 1.71) 2004 Modelled IHME
1.43 (1.16 - 1.74) 2003 Modelled IHME
1.46 (1.19 - 1.78) 2002 Modelled IHME
1.49 (1.22 - 1.82) 2001 Modelled IHME
1.52 (1.24 - 1.85) 2000 Modelled IHME
1.54 (1.26 - 1.88) 1999 Modelled IHME
1.55 (1.27 - 1.90) 1998 Modelled IHME
1.57 (1.29 - 1.92) 1997 Modelled IHME
1.59 (1.30 - 1.94) 1996 Modelled IHME
1.6 (1.31 - 1.96) 1995 Modelled IHME
1.61 (1.32 - 1.97) 1994 Modelled IHME
1.63 (1.34 - 1.98) 1993 Modelled IHME
1.64 (1.34 - 1.99) 1992 Modelled IHME
1.65 (1.35 - 1.99) 1991 Modelled IHME
1.66 (1.35 - 2.02) 1990 Modelled IHME
0.5 (0.30 - 0.60) 2015 Modelled Blach et al, 2017
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
48.69 2014 Survey/reported EMCDDA
24.08 2011 Survey/reported EMCDDA
24.44 2009 Survey/reported EMCDDA
22.62 2008 Survey/reported EMCDDA
25.73 2007 Survey/reported EMCDDA
28.91 2006 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.51 (0.28 - 0.54) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0.5 (0.20 - 1.10) 2009 Survey/reported Treso B, 2012
0.8 (0.40 - 2.70) 2014 Survey/reported Gower et al, 2014
0.8 (0.40 - 2.70) 2014 Survey/reported Gower et al, 2014
0.5 (0.20 - 1.10) 2009 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
46.6 (30.40 - 62.80) 2015 Modelled Degenhardt L et al, 2017
24.1 (20.80 - 27.60) 2011 Survey/reported EMCDDA
49.7 2015 Survey/reported ECDC
Showing out of
Show more
People who have ever injected drugs (PWID)
Download
Value (%) Year Type Source
49.7 2015 Survey/reported EMCDDA
Prisoners
Download
Value (%) Year Type Source
4.9 (4.30 - 5.60) 2009 Survey/reported Treso B et al, 2012
4.9 2012 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
172,599 (140,133 - 209,961) 1990 Modelled IHME
171,314 (139,758 - 206,785) 1991 Modelled IHME
169,895 (139,238 - 205,858) 1992 Modelled IHME
168,327 (138,344 - 205,012) 1993 Modelled IHME
166,702 (136,765 - 203,616) 1994 Modelled IHME
165,022 (135,001 - 202,063) 1995 Modelled IHME
163,273 (133,998 - 199,787) 1996 Modelled IHME
161,416 (132,219 - 197,245) 1997 Modelled IHME
159,373 (130,337 - 195,174) 1998 Modelled IHME
157,131 (128,560 - 191,927) 1999 Modelled IHME
154,742 (126,075 - 188,818) 2000 Modelled IHME
151,892 (123,906 - 185,532) 2001 Modelled IHME
148,468 (120,775 - 181,127) 2002 Modelled IHME
144,845 (117,617 - 176,771) 2003 Modelled IHME
141,458 (114,557 - 172,973) 2004 Modelled IHME
138,721 (112,143 - 169,552) 2005 Modelled IHME
136,615 (111,080 - 166,823) 2006 Modelled IHME
134,771 (109,958 - 164,669) 2007 Modelled IHME
133,077 (108,582 - 162,601) 2008 Modelled IHME
131,389 (106,880 - 160,528) 2009 Modelled IHME
129,557 (105,563 - 157,927) 2010 Modelled IHME
127,554 (104,088 - 154,873) 2011 Modelled IHME
125,477 (103,118 - 152,463) 2012 Modelled IHME
123,442 (101,600 - 150,327) 2013 Modelled IHME
121,548 (99,465 - 148,092) 2014 Modelled IHME
119,860 (97,939 - 146,537) 2015 Modelled IHME
118,158 (96,646 - 143,685) 2016 Modelled IHME
117,018 (94,985 - 143,291) 2017 Modelled IHME
116,715 (94,972 - 143,165) 2018 Modelled IHME
116,957 (94,966 - 143,818) 2019 Modelled IHME
52,000 (29,000 - 55,000) 2015 Modelled Blach et al, 2017
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
11,400 (6,300 - 12,100) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
6.65 (4.67 - 9.31) 2019 Modelled IHME
6.72 (4.89 - 9.28) 2018 Modelled IHME
6.56 (4.88 - 8.94) 2017 Modelled IHME
6.53 (4.87 - 8.88) 2016 Modelled IHME
6.76 (5.04 - 9.07) 2015 Modelled IHME
6.8 (5.06 - 9.16) 2014 Modelled IHME
6.96 (5.21 - 9.33) 2013 Modelled IHME
7.53 (5.65 - 10.10) 2012 Modelled IHME
8.08 (6.07 - 10.80) 2011 Modelled IHME
8.67 (6.54 - 11.60) 2010 Modelled IHME
9.27 (7 - 12.40) 2009 Modelled IHME
9.54 (7.25 - 12.80) 2008 Modelled IHME
10.1 (7.65 - 13.30) 2007 Modelled IHME
10.1 (7.61 - 13.30) 2006 Modelled IHME
10.3 (7.76 - 13.70) 2005 Modelled IHME
10.4 (7.80 - 13.70) 2004 Modelled IHME
10.7 (7.96 - 14.10) 2003 Modelled IHME
10.7 (7.96 - 14.10) 2002 Modelled IHME
10.8 (8.08 - 14.40) 2001 Modelled IHME
11.3 (8.39 - 15.10) 2000 Modelled IHME
12.2 (9.07 - 16.40) 1999 Modelled IHME
12.5 (9.31 - 16.70) 1998 Modelled IHME
12.5 (9.31 - 16.70) 1997 Modelled IHME
13 (9.70 - 17.30) 1996 Modelled IHME
14.5 (10.90 - 19.20) 1995 Modelled IHME
14.8 (11.20 - 19.60) 1994 Modelled IHME
14.6 (11.10 - 19.40) 1993 Modelled IHME
13.8 (10.50 - 18.10) 1992 Modelled IHME
12.3 (9.46 - 16.10) 1991 Modelled IHME
11.7 (9 - 15.20) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
644 (452 - 900) 2019 Modelled IHME
653 (475 - 902) 2018 Modelled IHME
640 (476 - 872) 2017 Modelled IHME
639 (477 - 869) 2016 Modelled IHME
664 (495 - 891) 2015 Modelled IHME
669 (499 - 903) 2014 Modelled IHME
687 (515 - 922) 2013 Modelled IHME
745 (560 - 1,000) 2012 Modelled IHME
803 (603 - 1,072) 2011 Modelled IHME
864 (651 - 1,158) 2010 Modelled IHME
926 (700 - 1,242) 2009 Modelled IHME
956 (727 - 1,285) 2008 Modelled IHME
1,010 (768 - 1,337) 2007 Modelled IHME
1,015 (766 - 1,341) 2006 Modelled IHME
1,043 (783 - 1,380) 2005 Modelled IHME
1,049 (789 - 1,383) 2004 Modelled IHME
1,080 (807 - 1,429) 2003 Modelled IHME
1,085 (809 - 1,437) 2002 Modelled IHME
1,101 (822 - 1,464) 2001 Modelled IHME
1,153 (856 - 1,538) 2000 Modelled IHME
1,247 (928 - 1,677) 1999 Modelled IHME
1,280 (954 - 1,717) 1998 Modelled IHME
1,283 (956 - 1,718) 1997 Modelled IHME
1,338 (998 - 1,783) 1996 Modelled IHME
1,491 (1,125 - 1,983) 1995 Modelled IHME
1,524 (1,155 - 2,025) 1994 Modelled IHME
1,515 (1,145 - 2,009) 1993 Modelled IHME
1,428 (1,092 - 1,877) 1992 Modelled IHME
1,280 (982 - 1,673) 1991 Modelled IHME
1,213 (935 - 1,577) 1990 Modelled IHME
965 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
26 (18 - 34) 2019 Modelled IHME
26 (18 - 34) 2018 Modelled IHME
26 (18 - 34) 2017 Modelled IHME
26 (18 - 34) 2016 Modelled IHME
26 (18 - 34) 2015 Modelled IHME
26 (18 - 34) 2014 Modelled IHME
26 (18 - 34) 2013 Modelled IHME
25 (18 - 33) 2012 Modelled IHME
25 (18 - 33) 2011 Modelled IHME
25 (18 - 33) 2010 Modelled IHME
25 (18 - 33) 2009 Modelled IHME
25 (18 - 32) 2008 Modelled IHME
25 (18 - 32) 2007 Modelled IHME
25 (18 - 32) 2006 Modelled IHME
25 (18 - 32) 2005 Modelled IHME
25 (17 - 32) 2004 Modelled IHME
24 (17 - 32) 2003 Modelled IHME
24 (17 - 32) 2002 Modelled IHME
25 (17 - 32) 2001 Modelled IHME
24 (17 - 32) 2000 Modelled IHME
24 (17 - 32) 1999 Modelled IHME
25 (17 - 32) 1998 Modelled IHME
25 (17 - 32) 1997 Modelled IHME
25 (17 - 33) 1996 Modelled IHME
25 (17 - 33) 1995 Modelled IHME
25 (17 - 32) 1994 Modelled IHME
24 (17 - 32) 1993 Modelled IHME
24 (17 - 32) 1992 Modelled IHME
24 (17 - 32) 1991 Modelled IHME
24 (17 - 32) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
838 2017 Survey/reported ECDC, 2019
838 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
21 2017 Survey/reported EMCDDA, 2019
48 (32 - 91) 2016 Survey/reported Hungary National Institute for Health Development, 2016
21 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Few (1-10%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.68 (%)
2019
(0.63 - 0.74(%))
IHME
HCV (RNA/cAg+)
1.21 (%)
2019
(0.98 - 1.49(%))
IHME

Survey/surveillance

HBV (HBsAg+)
0.4 (%)
2009
(0.1 - 1(%))
Treso B, 2012
HCV (anti-HCV)
0.8 (%)
2014
(0.4 - 2.7(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
1,115
2019
(830 - 1,477)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
644
2019
(452 - 900)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.22 (%)
2019, latest modelled
(0.16 - 0.30(%))
IHME

Prevalence PWID

HCV
49.70 (%)
2015, survey/surveillance
ECDC

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
21
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Latest news

View all

News

Resources

Programs

Partners